MedApp SA (MDA) Stock Analysis | Price, Returns, Financials & Key Metrics

Price Point

High/Low

1Day

52 Week

Valuation

Technical

Day's Volume

CASH

N/A

Shareholding

FII

N/A

DII

N/A

Promoter

N/A

Score

Click here to find our call on this stock

Strong Sell

Sell

Hold

Buy

Strong Buy

MarketsMojo — Loved in India, Now Global

The power of Mojo is now in 29 countries. Explore global equities with the same cutting-edge features you love.Unlock 29 Markets

Dashboard

Poor long term growth as Operating profit has grown by an annual rate -193.11% of over the last 5 years

INTEREST(HY) At PLN 0.13 MM has Grown at 385.19%
NET SALES(Q) At PLN 1.29 MM has Fallen at -30.36%
PRE-TAX PROFIT(Q) At PLN -0.45 MM has Fallen at -1,732.65%

Risky -

Consistent Underperformance against the benchmark over the last 3 years

Mojo Parameters

Stock DNA

Industry

Software Products

Market cap

PLN 27 Million (Micro Cap)

P/E

NA (Loss Making)

Industry P/E

Dividend Yield

0.00%

Debt Equity

0.05

Return on Equity

-3.08%

Price to Book

1.10

Revenue and Profits:

Net Sales:

1 Million

(Quarterly Results - Mar 2025)

Net Profit:

0 Million

Total Returns

Total Returns (Price + Dividend)

TimePeriod

Price Return

Dividend Return

Total Return

3 Months

-43.89%

6 Months

-36.08%

1 Year

-38.79%

2 Years

-70.29%

3 Years

-74.1%

4 Years

-89.31%

5 Years

-89.69%

MedApp SA for the last several years.

Risk Adjusted Returns v/s

News & Corporate Actions

News

No Recent News for the Company

Announcements

No announcement available

Corporate Actions

No corporate action available

Key Factors

Quality key factors

Factor

Value

Sales Growth (5y)

12.93%

EBIT Growth (5y)

-193.11%

EBIT to Interest (avg)

0.83

Debt to EBITDA (avg)

0.31

Net Debt to Equity (avg)

0.05

Sales to Capital Employed (avg)

0.23

Tax Ratio

2.30%

Dividend Payout Ratio

Pledged Shares

Institutional Holding

ROCE (avg)

7.13%

ROE (avg)

7.53%

Valuation key factors

Factor

Value

P/E Ratio

NA (Loss Making)

Industry P/E

Price to Book Value

1.63

EV to EBIT

-41.72

EV to EBITDA

20.00

EV to Capital Employed

1.60

EV to Sales

6.74

PEG Ratio

Dividend Yield

ROCE (Latest)

-3.79%

ROE (Latest)

-3.08%

Technicals key factors

Indicator

Weekly

Monthly

MACD

Bearish

Mildly Bullish

RSI

No Signal

Bollinger Bands

Bearish

Moving Averages

Bearish (Daily)

KST

Bearish

Mildly Bullish

Dow Theory

No Trend

OBV

Mildly Bearish

Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned

Shareholding

Shareholding Snapshot

No data for shareholding present.

Shareholding Compare (%holding)

No data for shareholding present.

Financial

[
  {
    "link": "quarterly",
    "btn_text": "All Quarterly Results",
    "header": "Quarterly Results Snapshot (Consolidated) - Mar'25 - QoQ",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "QoQ Growth in quarter ended Mar 2025 is -23.53% vs -32.00% in Dec 2024",
        "dir": 1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "QoQ Growth in quarter ended Mar 2025 is -66.67% vs -137.50% in Dec 2024",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Mar'25",
        "Dec'24",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "1.30",
          "val2": "1.70",
          "chgp": "-23.53%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "0.40",
          "val2": "0.90",
          "chgp": "-55.56%",
          "chgp_class": "negative"
        },
        {
          "field": "Interest",
          "val1": "0.00",
          "val2": "0.10",
          "chgp": "-100.00%",
          "chgp_class": "positive"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "-0.50",
          "val2": "-0.30",
          "chgp": "-66.67%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "-427.20%",
          "val2": "-151.50%",
          "chgp": "-27.57%",
          "chgp_class": "negative"
        }
      ]
    }
  },
  {
    "link": "annual",
    "btn_text": "All Annual Results",
    "header": "Annual Results Snapshot (Consolidated) - Dec'24",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in year ended Dec 2024 is 26.32% vs -14.93% in Dec 2023",
        "dir": 1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in year ended Dec 2024 is 167.74% vs -616.67% in Dec 2023",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Dec'24",
        "Dec'23",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "7.20",
          "val2": "5.70",
          "chgp": "26.32%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "5.90",
          "val2": "-1.30",
          "chgp": "553.85%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "0.10",
          "val2": "0.20",
          "chgp": "-50.00%",
          "chgp_class": "positive"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "-1.50",
          "chgp": "100.00%",
          "chgp_class": "positive"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "2.10",
          "val2": "-3.10",
          "chgp": "167.74%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "347.40%",
          "val2": "-226.00%",
          "chgp": "57.34%",
          "chgp_class": "positive"
        }
      ]
    }
  }
]

Quarterly Results Snapshot (Consolidated) - Mar'25 - QoQ

Mar'25

Dec'24

Change(%)

Net Sales

1.30

1.70

-23.53%

Operating Profit (PBDIT) excl Other Income

0.40

0.90

-55.56%

Interest

0.00

0.10

-100.00%

Exceptional Items

0.00

Consolidate Net Profit

-0.50

-0.30

-66.67%

Operating Profit Margin (Excl OI)

-427.20%

-151.50%

-27.57%

USD in Million.

Compare with Peers

Net Sales

QoQ Growth in quarter ended Mar 2025 is -23.53% vs -32.00% in Dec 2024

Consolidated Net Profit

QoQ Growth in quarter ended Mar 2025 is -66.67% vs -137.50% in Dec 2024

All Quarterly Results

Annual Results Snapshot (Consolidated) - Dec'24

Dec'24

Dec'23

Change(%)

Net Sales

7.20

5.70

26.32%

Operating Profit (PBDIT) excl Other Income

5.90

-1.30

553.85%

Interest

0.10

0.20

-50.00%

Exceptional Items

0.00

-1.50

100.00%

Consolidate Net Profit

2.10

-3.10

167.74%

Operating Profit Margin (Excl OI)

347.40%

-226.00%

57.34%

USD in Million.

Compare with Peers

Net Sales

YoY Growth in year ended Dec 2024 is 26.32% vs -14.93% in Dec 2023

Consolidated Net Profit

YoY Growth in year ended Dec 2024 is 167.74% vs -616.67% in Dec 2023

All Annual Results

Company CV

About MedApp SA

MedApp SA

Software Products

Medapp SA is a Poland-based company engaged in the software development. The Company provides a software application, named Carna Life, which is used in telemedicine sector. Carna Life serves as communication channel between doctors and patient. Carna Life is a telemedicine system that enables patients to upload test results and receive doctor's interpretation. The application operates in online (upload and download of data) and offline (review of data) mode. Carna Life provides statistics, graphic visualizations and tables with interpreted data. The Company is controlled by Moonrock Enterprise SA.

Company Coordinates

Company Details

Longinusa Podbipiety 29 , KRAKOW None : 31-517

Tel: 48 22 8455555

http://www.medapp.pl/

Registrar Details